Mammographic Breast Density

2

Review clinical trials related to Mammographic Breast Density. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PERsonalized Mammographic Screening in Norway

The aim of this study is to assess attendance among women invited to additional breast imaging because they were identified as having an increased risk of breast cancer at screening. High-risk women were defined in two studies: Study A; women with high mammographic density, representing approximately 3-5% of screened women, and Study B; women with a false-positive screening result. Women in Study A will be offered an additional screening examination with digital breast tomosynthesis immediately within 6 months after the screening examination. Women in Study B will be offered an additional standard digital mammography examination one year after their initial screening.

Participants needed: 3,000
Trial details
Age: 50-71Biological sex: FemaleType: ObservationalSponsor: Norwegian Institute of Public HealthUpdated: Jan 29, 2026Duration: 2 Years
Eligibility criteria

invited to screening [+1]

Opted out or not signed written consent related to the study [+1]

Status: Recruiting

Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening

The purpose of this study is to evaluate how well women may adopt a Contrast-enhanced Spectral Mammography (CESM) as their yearly breast screening test compared to the standard 2-D or 3-D mammogram.

Participants needed: 210
Trial details
Age: 40-69Biological sex: FemaleType: InterventionalSponsor: University of VirginiaUpdated: Nov 17, 2022Locations: 1
Eligibility criteria

• Female [+3]

• No mammogram within last 24 months [+12]